Company Filing History:
4 out of 9 
1 out of 2 Years Active: 2014-2021
Title: Hilke Brühl: Innovator in Diagnostic Methods
Introduction
Hilke Brühl is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of diagnostics, particularly in the development of methods for detecting interleukin-3 levels in human samples. With a total of 5 patents to his name, Brühl's work has the potential to impact the diagnosis and treatment of various diseases.
Latest Patents
Brühl's latest patents include a diagnostic method for determining the presence and amount of human interleukin-3 in a sample using novel IL-3 antibodies. This method involves adding an anti-IL-3-antibody, fragment, or construct to a sample under conditions that allow for binding to IL-3. The amount of antibody-bound IL-3 is then detected, with the anti-IL-3-antibody being clone 13. Additionally, he has developed novel anti-IL-3 antibodies that specifically bind to an epitope within the N-terminal 20 amino acids of human IL-3. These antibodies can be utilized in diagnostic methods and pharmaceutical compositions for treating diseases associated with elevated IL-3 levels, such as rheumatoid arthritis.
Career Highlights
Brühl has worked at prominent institutions, including Universitätsklinikum Regensburg and Klinikum der Universität Regensburg. His experience in these organizations has allowed him to advance his research and contribute to the medical field significantly.
Collaborations
Throughout his career, Brühl has collaborated with notable colleagues, including Matthias Mack and Kerstin Renner. These partnerships have fostered innovation and the development of new diagnostic techniques.
Conclusion
Hilke Brühl's contributions to the field of diagnostics, particularly in relation to interleukin-3, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical diagnostics and treatment options.